Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1973 8
1974 5
1975 3
1976 1
1977 3
1978 1
1979 2
1980 1
1981 2
1982 3
1984 2
1985 3
1986 4
1987 8
1988 6
1989 3
1990 1
1991 1
1992 4
1993 10
1994 9
1995 2
1996 4
1997 5
1999 8
2000 5
2001 1
2002 4
2003 2
2004 4
2005 3
2006 6
2007 3
2008 1
2009 3
2010 2
2011 4
2012 4
2013 6
2014 3
2015 3
2016 4
2017 4
2018 7
2019 9
2020 7
2021 16
2022 15
2023 6
2024 9
2025 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

227 results

Results by year

Filters applied: . Clear all
Page 1
Levofloxacin Preventive Treatment in Children Exposed to MDR Tuberculosis.
Hesseling AC, Purchase SE, Martinson NA, Fairlie L, Schaaf HS, Brigden J, Staples S, Gibb DM, Garcia-Prats A, Conradie F, McGowan C, Layton C, Batist E, Demers AM, Nyamathe S, Frigati L, Turner R, Duong T, Seddon JA. Hesseling AC, et al. Among authors: layton c. N Engl J Med. 2024 Dec 19;391(24):2315-2326. doi: 10.1056/NEJMoa2314318. N Engl J Med. 2024. PMID: 39693542 Clinical Trial.
Facing Fear.
Layton CA. Layton CA. J Palliat Med. 2019 Aug;22(8):1001. doi: 10.1089/jpm.2018.0589. J Palliat Med. 2019. PMID: 31380725 No abstract available.
A Meta-Analysis of Levofloxacin for Contacts of Multidrug-Resistant Tuberculosis.
Duong T, Brigden J, Simon Schaaf H, Garden F, Marais BJ, Anh Nguyen T, White IR, Gibb DM, Nhung NV, Martinson NA, Fairlie L, Martinez L, Layton C, Benedetti A, Marks GB, Turner RM, Seddon JA, Hesseling AC, Fox GJ. Duong T, et al. Among authors: layton c. NEJM Evid. 2025 Jan;4(1):EVIDoa2400190. doi: 10.1056/EVIDoa2400190. Epub 2024 Dec 18. NEJM Evid. 2025. PMID: 39693627
Exploring hepatitis C virus testing and treatment engagement over time in Melbourne, Australia: a study protocol for a longitudinal cohort study (EC-Experience Cohort study).
O'Keefe D, Gunn J, Ryan K, Djordjevic F, Kerr P, Gold J, Elsum I, Layton C, Chan K, Dietze P, Higgs P, Doyle J, Stoové MA, Hellard M, Pedrana AE. O'Keefe D, et al. Among authors: layton c. BMJ Open. 2022 Jan 4;12(1):e057618. doi: 10.1136/bmjopen-2021-057618. BMJ Open. 2022. PMID: 34983773 Free PMC article.
Increasing hepatitis C testing and linkage to care: Results of a testing campaign with incentives at primary care clinics in Melbourne, Australia.
Chan K, Elsum I, Gold J, Layton C, Accadia L, Bryant M, Gunn J, Djordjevic F, Purcell I, Dicka J, Forrest M, Crawford S, Hellard M, Pedrana A; Eliminate Hepatitis C Partnership. Chan K, et al. Among authors: layton c. J Viral Hepat. 2021 Mar;28(3):569-572. doi: 10.1111/jvh.13447. Epub 2020 Dec 12. J Viral Hepat. 2021. PMID: 33259117 No abstract available.
227 results